Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (409)
|
Core Tip (456)
|
Full Article (HTML) (1777)
|
Figures (1-1) (298)
|
Full Article (PDF)-1204K (119)
|
Full Article with Cover (PDF)-11949K (103)
|
Full Article (XML)-236K (64)
|
Audio-1342K (5)
|
Peer-Review Report-230K (62)
|
Answering Reviewers-97K (59)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4653)
|
Similar Articles (75)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (413)
|
Core Tip (472)
|
Full Article (HTML) (1156)
|
Tables (1-1) (357)
|
Full Article (PDF)-358K (104)
|
Full Article with Cover (PDF)-11106K (83)
|
Full Article (XML)-54K (55)
|
Audio-1072K (7)
|
Peer-Review Report-236K (54)
|
Answering Reviewers-62K (49)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3778)
|
Similar Articles (19)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (458)
|
Core Tip (395)
|
Full Article (HTML) (4085)
|
Figures (1-2) (300)
|
Tables (1-5) (302)
|
Full Article (PDF)-1655K (180)
|
Full Article with Cover (PDF)-12399K (136)
|
Full Article (XML)-226K (57)
|
Audio-1259K (4)
|
Peer-Review Report-216K (62)
|
Answering Reviewers-145K (56)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (6813)
|
Similar Articles (61)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (477)
|
Core Tip (403)
|
Full Article (HTML) (2840)
|
Figures (1-1) (318)
|
Full Article (PDF)-601K (202)
|
Full Article with Cover (PDF)-11346K (78)
|
Full Article (XML)-89K (66)
|
Audio-384K (5)
|
Peer-Review Report-180K (54)
|
Answering Reviewers-74K (61)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (10)
|
Total Visits (5407)
|
Similar Articles (331)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (471)
|
Core Tip (423)
|
Article Highlights (436)
|
Full Article (HTML) (1826)
|
Figures (1-4) (295)
|
Tables (1-3) (273)
|
Full Article (PDF)-1672K (97)
|
Full Article with Cover (PDF)-12418K (102)
|
Full Article (XML)-173K (54)
|
Audio-467K (6)
|
Peer-Review Report-182K (52)
|
Answering Reviewers-71K (75)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5319)
|
Similar Articles (1965)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes

World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (443)
|
Core Tip (448)
|
Article Highlights (529)
|
Full Article (HTML) (1655)
|
Figures (1-3) (318)
|
Tables (1-2) (286)
|
Full Article (PDF)-1874K (96)
|
Full Article with Cover (PDF)-12619K (94)
|
Full Article (XML)-114K (50)
|
Audio-386K (8)
|
Peer-Review Report-233K (67)
|
Answering Reviewers-161K (63)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5941)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication

World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (380)
|
Core Tip (387)
|
Article Highlights (439)
|
Full Article (HTML) (1133)
|
Figures (1-4) (271)
|
Full Article (PDF)-5746K (92)
|
Full Article with Cover (PDF)-16492K (78)
|
Full Article (XML)-96K (61)
|
Audio-3997K (6)
|
Peer-Review Report-192K (52)
|
Answering Reviewers-146K (59)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (3936)
|
Similar Articles (41)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (430)
|
Core Tip (416)
|
Article Highlights (453)
|
Full Article (HTML) (2040)
|
Figures (1-4) (260)
|
Tables (1-5) (292)
|
Full Article (PDF)-6006K (120)
|
Full Article with Cover (PDF)-16750K (92)
|
Full Article (XML)-200K (55)
|
Audio-376K (3)
|
Peer-Review Report-182K (57)
|
Answering Reviewers-60K (66)
|
Supplementary Material-355K (69)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (6431)
|
Similar Articles (1818)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis

World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (388)
|
Core Tip (451)
|
Article Highlights (450)
|
Full Article (HTML) (1294)
|
Figures (1-4) (281)
|
Tables (1-4) (291)
|
Full Article (PDF)-5941K (93)
|
Full Article with Cover (PDF)-16687K (67)
|
Full Article (XML)-115K (54)
|
Audio-187K (9)
|
Peer-Review Report-215K (49)
|
Answering Reviewers-37K (62)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (5179)
|
Similar Articles (2409)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (406)
|
Core Tip (404)
|
Full Article (HTML) (1056)
|
Figures (1-1) (334)
|
Full Article (PDF)-5068K (82)
|
Full Article with Cover (PDF)-15813K (69)
|
Full Article (XML)-63K (49)
|
Audio-811K (3)
|
Peer-Review Report-266K (59)
|
Answering Reviewers-225K (55)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (4079)
|
Similar Articles (4145)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (403)
|
Core Tip (416)
|
Full Article (HTML) (1032)
|
Full Article (PDF)-325K (89)
|
Full Article with Cover (PDF)-11079K (70)
|
Full Article (XML)-24K (62)
|
Audio-243K (1)
|
Peer-Review Report-215K (47)
|
Answering Reviewers-19K (44)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (2897)
|
Similar Articles (390)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open